4.5 Article

Dynamic consent: a patient interface for twenty-first century research networks

Journal

EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 23, Issue 2, Pages 141-146

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2014.71

Keywords

-

Funding

  1. Wellcome Trust Award [096599/2/11/Z]
  2. EU F7 project BIOSHARE
  3. Innovative Medicines Initiative Joint Undertaking (StemBANCC) [115439]
  4. European Union's Seventh Framework Programme (FP7)
  5. EFPIA companies'
  6. Innovative Medicines Initiative joint Undertaking [115005]
  7. NIHR Biomedical Research Centre, Oxford
  8. Technology Strategy Board
  9. Engineering and Physical Sciences Research Council
  10. Economic and Social Research Council [EP/G002541/1]
  11. EPSRC [EP/G002541/2, EP/G002541/1] Funding Source: UKRI
  12. Engineering and Physical Sciences Research Council [EP/G002541/2, EP/G002541/1] Funding Source: researchfish

Ask authors/readers for more resources

Biomedical research is being transformed through the application of information technologies that allow ever greater amounts of data to be shared on an unprecedented scale. However, the methods for involving participants have not kept pace with changes in research capability. In an era when information is shared digitally at the global level, mechanisms of informed consent remain static, paper-based and organised around national boundaries and legal frameworks. Dynamic consent (DC) is both a specific project and a wider concept that offers a new approach to consent; one designed to meet the needs of the twenty-first century research landscape. At the heart of DC is a personalised, digital communication interface that connects researchers and participants, placing participants at the heart of decision making. The interface facilitates two-way communication to stimulate a more engaged, informed and scientifically literate participant population where individuals can tailor and manage their own consent preferences. The technical architecture of DC includes components that can securely encrypt sensitive data and allow participant consent preferences to travel with their data and samples when they are shared with third parties. In addition to improving transparency and public trust, this system benefits researchers by streamlining recruitment and enabling more efficient participant recontact. DC has mainly been developed in biobanking contexts, but it also has potential application in other domains for a variety of purposes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available